In this week’s show
00:44 – Q1:What are your views on MHK?
03:27 – Q2:Do you have an opinion on Firebrick Pharma which has started marketing their anti viral nasal spray in America ?
07:03 – Q3:Woodside announced (on 25 August) an 11% increase to their net profit. Is it possible to have a reasonable estimate of the dividends payable? The recent September dividend paid was $1.02. That is 18 % less than the dividend paid In September last year. The March 2024 dividend was $.91. Any thoughts regarding what the March 2025 dividend may be? As a general, broad rule, dividends follow earnings. Dividend yields become increasingly important with future reductions in interest rates.
12:13 – Q4:Citi has cut their price target to $23. (The shares closed at $25.20 today.) Macquarie’s recent target was $33.00. Other Analysts have their targets at $33.50, $31.70, $30.70, $30.00, $28.50 and $28.10. Do you know the proportions of Gas, Oil and Hydrocarbon produced by Woodside, as a percentage of their sales? In the period from January to August, sales of EV cars in Australia was 7.6.% of total vehicle sales. Hybrid vehicle sales was 15.5 % for the same period. That is a world wide trend at the moment. That still leaves 77% of sales being for “traditional” vehicles. Woodside may have a great opportunity to capitalize on the growing need for hydrocarbon?
13:28 – Q5:Major Investment Funds’ interest in Woodside is very interesting. Black Rock increased their holding from 6.13% to 7.14% on 5/2/24. State Street increased their holding from 5.04% to 6.08% on 1/4/24, and to 7.12% on 12/9/24. Australian super announced a 5.02% holding on 5/7/24. It appears that that was a block purchase. (95,290,819 shares.) They increased their holding to 6.14% on 28/8/24. There was “no shareholder sell activity.”
I sold some shares in Woodside the other day, to get set in another company. I don’t feel a burning need to sell any more. I would appreciate any thoughts that some-one may have with regard to Woodside.
15:00 – Q6:I bought into Pro Medicus Limited (PME) a few months ago at $130 and has quickly escalated to $180.I bought it following a news story in a rival investment advice firm which I receive emails. The chart is showing a spectacular upward trajectory and was wondering should I at least reduce my exposure by %50 as what goes up quickly can go down just as fast.The company even paid a small recent dividend. the P/E ratio is 220x.Just after your thoughts.
